Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...

Peptides offer a gentle yet powerful solution for ageing skin, hydration, and repair. While they don’t work overnight, ...

A natural antibacterial molecule shows clinical promise. Its unusual binding site is on an excellent target: ...

BioDuro has opened a new lab in Shanghai, China for highly potent compound synthesis at the hundred-gram scale.

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating resp ...

As interest in these compounds grows, many people are also seeking effective ways to anabolic steroids kaufen to maximize ...

Background Mechanical stress on the heart is commonly considered the sole stimulus explaining the synthesis and release of circulating natriuretic peptides and their derivatives. While one of the most ...

This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid ...